116 related articles for article (PubMed ID: 38277979)
1. Gynaecological follow-up for women of reproductive age with multiple sclerosis: The GYNESEP study.
Renaud J; Buissonnière P; Dulau C; Deloire M; Hontarrede F; Montcuquet A; Chansel-Debordeaux L; Hocké C; Ouallet JC; Ruet A; Bernard V
Mult Scler Relat Disord; 2024 Mar; 83():105448. PubMed ID: 38277979
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive practices and cervical screening in women with cystic fibrosis.
Rousset Jablonski C; Reynaud Q; Perceval M; Nove-Josserand R; Durupt S; Lega JC; Durieu I
Hum Reprod; 2015 Nov; 30(11):2547-51. PubMed ID: 26345688
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
4. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
6. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Colposcopic performance in a birth cohort previously eligible for human papillomavirus vaccination.
Sahlgren HAI; Elfgren K; Sparen P; Elfstrom MK
Am J Obstet Gynecol; 2022 May; 226(5):704.e1-704.e9. PubMed ID: 34954217
[TBL] [Abstract][Full Text] [Related]
9. Perception and knowledge of human papillomavirus (HPV) vaccine for cervical cancer prevention among fully vaccinated female university students in the era of HPV vaccination: a cross-sectional study.
Chew KT; Kampan N; Shafiee MN
BMJ Open; 2021 Dec; 11(12):e047479. PubMed ID: 34876417
[TBL] [Abstract][Full Text] [Related]
10. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
11. Provision of screening services for cervical and breast cancer - A scientific study commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG).
Vieira-Coimbra M; Nogueira-Martins N; Zadykowicz R; Rodrigues Gaspar H; Calleja-Agius J; Pakiz M; Mukhopadhyay S; Mahmood T
Eur J Obstet Gynecol Reprod Biol; 2023 Oct; 289():208-216. PubMed ID: 37679212
[TBL] [Abstract][Full Text] [Related]
12. Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy.
Haker MC; Frahm N; Hecker M; Langhorst SE; Mashhadiakbar P; Debus JL; Streckenbach B; Baldt J; Heidler F; Zettl UK
Ther Adv Drug Saf; 2023; 14():20420986221143830. PubMed ID: 37007872
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
[TBL] [Abstract][Full Text] [Related]
16. Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology.
Dorton BJ; Vitonis AF; Feldman S
Hum Vaccin Immunother; 2016 Jun; 12(6):1639-45. PubMed ID: 26839185
[TBL] [Abstract][Full Text] [Related]
18. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
19. Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort.
Liu Z; Li P; Zeng X; Yao X; Sun Y; Lin H; Shen P; Sun F; Zhan S
BMC Public Health; 2022 Nov; 22(1):2117. PubMed ID: 36401179
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
Kumakech E; Andersson S; Wabinga H; Musubika C; Kirimunda S; Berggren V
BMC Womens Health; 2017 Jun; 17(1):40. PubMed ID: 28576143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
